Haller Julia A 4

What Happened

• Julia A. Haller, a non-employee director of Bristol Myers Squibb Co. (BMY), was granted 3,996.367 Deferred Share Units on 2026-02-01. The units are recorded at $55.05 each for a total value of $220,000. This is an award (derivative grant) under the company's director compensation plan, not an open‑market purchase or sale.

Key Details

• Transaction date: 2026-02-01; Form 4 filed: 2026-02-03 (timely).
• Grant: 3,996.367 Deferred Share Units at $55.05 each = $220,000.
• Nature: Derivative award (Deferred Share Units under the 1987 Deferred Compensation Plan for Non-Employee Directors).
• Shares owned after transaction: Not specified in this filing.
• Footnotes:
  • F1: Each Deferred Share Unit will convert into a share of common stock upon settlement; units become settleable when the reporting person ceases to be a director or at a previously specified future date.
  • F2: Amount includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Context

• Deferred Share Units are common director compensation and represent a future right to receive shares (or their value) rather than an immediate stock purchase — they do not directly signal a personal buy or sell decision. This grant appears to be routine director pay and will convert to actual shares only upon settlement per the plan terms.